By enhancing our understanding of the underlying mechanisms, particularly involving TRIM29 and PERK-mediated ER stress signaling pathways, future research can pave the way for novel, natural treatments for various inflammatory diseases, including inflammatory bowel disease, arthritis, and skin inflammation. This evidence concerns the gene EIF2AK3 and arthritic joint disease.